Figure 7

Relapse free survival of cases with CD66c ^pos (blue line) or CD66c ^neg (red line) B-precursor ALL. Unselected consecutive patients treated on ALL BFM95 protocol (median follow up 3.64 years). Since surface CD66c associates with genotype, separate analyses for distinct genotype subgroups are shown.